Smell Retraining for Loss of Smell

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
UPMC Children's Hospital of Pittsburgh, Pittsburgh, PALoss of Smell+8 MoreSmell Retraining - Other
Eligibility
6 - 21
All Sexes
What conditions do you have?
Select

Study Summary

This trial will help researchers learn more about how to help people who have lost their sense of smell due to COVID-19.

Eligible Conditions
  • Loss of Smell
  • Anosmia
  • Coronavirus

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 6 Secondary · Reporting Duration: Baseline and 6 months after initial consult appointment

Month 12
Change in Sino-nasal Outcome Test-22 (SNOT-22) score from baseline to 12 month follow-up
Change in University of Pennsylvania Smell Identification Test (UPSIT) score from baseline to 12 month follow-up
Month 6
Change in Sino-nasal Outcome Test-22 (SNOT-22) score from baseline to 6 month follow-up
Change in University of Pennsylvania Smell Identification Test (UPSIT) score from baseline to 6 month follow-up
Week 12
Change in Sino-nasal Outcome Test-22 (SNOT-22) score from baseline to first follow-up
Change in University of Pennsylvania Smell Identification Test (UPSIT) score from baseline to first follow-up
Change in anxiety question score from baseline to first follow-up
Change in loss of smell question score from baseline to first follow-up
Change in loss of taste question score from baseline to first follow-up

Trial Safety

Trial Design

2 Treatment Groups

Smell Retraining Only
1 of 2
Smell Retraining + Budesonide
1 of 2

Active Control

Experimental Treatment

60 Total Participants · 2 Treatment Groups

Primary Treatment: Smell Retraining · No Placebo Group · Phase 1 & 2

Smell Retraining + BudesonideExperimental Group · 2 Interventions: Smell Retraining, Budesonide · Intervention Types: Other, Drug
Smell Retraining Only
Other
ActiveComparator Group · 1 Intervention: Smell Retraining · Intervention Types: Other
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Budesonide
FDA approved

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline and 6 months after initial consult appointment

Who is running the clinical trial?

Amanda StapletonLead Sponsor
Amanda L Stapleton, MDPrincipal InvestigatorUniversity of Pittsburgh

Eligibility Criteria

Age 6 - 21 · All Participants · 2 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Who else is applying?

What state do they live in?
Texas40.0%
South Carolina20.0%
New Mexico20.0%
Other20.0%
How old are they?
18 - 6575.0%
65+25.0%
What portion of applicants met pre-screening criteria?
Did not meet criteria100.0%
Why did patients apply to this trial?
  • "I'm a chef who has only been able to smell 3-4 times in the last 18 months, and only for 1 minute increments."
  • "I lost my sense of smell at the end of having Covid in May. It went completely. I went on steroids and it came back, but within days of finishing my course of steroids it went away again. It differs day to day - sometimes I can faintly smell my coffee, others not at all. I had a hypersensitive sense of smell before and I hate not being able to smell."
How many prior treatments have patients received?
050.0%
250.0%
What site did they apply to?
UPMC Children's Hospital of Pittsburgh100.0%
What questions have other patients asked about this trial?
  • "My financial situation has significantly worsened due to anosmia. Are the costs associated with trips to the hospital for the study offset?"

Frequently Asked Questions

Are people of all ages eligible for this clinical trial?

"Researchers are looking for participants who were born between 1999 and 2006." - Anonymous Online Contributor

Unverified Answer

What are the screening procedures for this test?

"The ideal participant for this clinical trial is a child or young adult aged 6-21 who currently suffers from anosmia. Additionally, it is imperative that potential subjects are able to take the UPSIT smell test, self-report any changes in their sense of smell, and commit to the assigned daily therapy." - Anonymous Online Contributor

Unverified Answer

For what purpose is Smell Retraining therapy most often used?

"Smell Retraining is a conventional medical intervention used to treat acute coryza. However, it can also be used in less common cases such as when patients suffer from proteinuria or Crohn disease." - Anonymous Online Contributor

Unverified Answer

How many people have been invited to participate in this research project?

"The latest information from clinicaltrials.gov suggests that this research study is still looking for participants. The 60 patients will be recruited from a single site, and the trial was first posted on September 30th, 2021." - Anonymous Online Contributor

Unverified Answer

Could you share some other studies that have used Smell Retraining?

"At present, there are 32 separate studies being conducted on smell retraining. 10 of those studies are in phase 3 clinical trials. Most of the trials for smell retraining are taking place in Xi'an, Shaanxi, but there are 992 locations around the world where these trials are being run." - Anonymous Online Contributor

Unverified Answer

Can patients still enroll in this experiment?

"Yes, the information available on clinicaltrials.gov verifies that this trial is still recruiting patients. This particular study was opened on September 30th, 2021 and was last updated October 5th, 2022. The research team is looking for 60 participants total from 1 location." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.